Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort

BACKGROUND: Heart failure is a highly prevalent cardiovascular complication among patients receiving long‐term hemodialysis, but the benefits of carvedilol, bisoprolol, and metoprolol controlled release/extended release on the outcomes of these patients remain unclear. In this study, we address the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Heart Assoc
Hoofdauteurs: Tang, Chao‐Hsiun, Wang, Chia‐Chen, Chen, Tso‐Hsiao, Hong, Chuang‐Ye, Sue, Yuh‐Mou
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2016
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4859376/
https://ncbi.nlm.nih.gov/pubmed/26738790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.002584
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items